Coherus BioSciences: Q1 Earnings Snapshot

Published: 2025-05-12 16:28:22 ET CHRS

Published on 05/12/2025 at 16:28

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $56.6 million in its first quarter.

The Redwood City, California-based company said it had a loss of 49 cents per share. Losses, adjusted to account for discontinued operations and stock option expense, were 35 cents per share.

The drug developer posted revenue of $7.6 million in the period, which did not meet Street forecasts. Four analysts surveyed by Zacks expected $52.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News